"Eli Lilly Revolutionizes Weight-Loss Treatment with Direct-to-Consumer Drug Delivery and Telehealth Services"
TL;DR Summary
WW International, known as WeightWatchers, saw its shares drop significantly after Eli Lilly launched a digital platform, LillyDirect, to deliver weight-loss drugs, which directly competes with WeightWatchers' market. Despite the decline, analysts believe WW's strong brand could still thrive in the weight-loss space. Other companies in the online prescription weight-loss market also experienced share price declines following the announcement.
Topics:business##business-and-finance#digitalhealthcare#elililly#stockmarket#weightlossdrug#weightwatchers
- WeightWatchers Sinks as Eli Lilly Launches Weight-Loss Drug Delivery Yahoo Finance
- Eli Lilly to sell weight-loss drug Zepbound directly to patients and offer home-delivery Axios
- Eli Lilly launches service to connect patients with telehealth care, deliver medications to their homes CNN
- You Can Now Get Weight-Loss Drugs Right From Eli Lilly The Wall Street Journal
- Open Letter Regarding the Use of Mounjaro® (tirzepatide) and Zepbound™ (tirzepatide) | Eli Lilly and Company Investors | Eli Lilly and Company
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
87%
462 → 59 words
Want the full story? Read the original article
Read on Yahoo Finance